Augmentation of treatment for patients with hypertension

Download the Paper

Description: This guidance suggests possible augmentation of the basic treatment of patients with hypertension because of current co-morbiidities

Publet Introduction:

Approximately 50 million people have hypertension. Many agents with differing efficacy, side effects, dosing schedules, and costs are available to treat hypertension. Joint National Committee (JNC) guidelines attempt to simplify this decision by recommending specific agents based on special considerations such as comorbidities.


  Information
Guideline objectives

Management of patients with hypertension and one or more co-morbid conditions

Target setting General practice
Target users General physicians and specialist nurses
Overview
Provenance 7.No provenance has been assigned (default value)
Management
  • Author: Unknown
  • Release date:
  • Status: Draft - Under Review
  • History: Prepared for a trial with UK pharmacists, not deployed to date
Safety case Informally carried out by developers but not documented
Sources

Not recorded

References